Royal Bank of Canada
BNGO icon

Royal Bank of Canada’s Bionano Genomics BNGO Stock Holding History

Royal Bank of Canada’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
11
-1
-8% -$1 ﹤0.01% 7133
2025
Q4 		$0 Sell
12
-1
-8% -$2 ﹤0.01% 7174
2025
Q3 		$0 Hold
13
– – ﹤0.01% 7138
2025
Q2 		$0 Hold
13
– – ﹤0.01% 7034
2025
Q1 		$0 Sell
13
-2
-13% -$13 ﹤0.01% 6827
2024
Q4 		$0 Buy
15
+10
+200% +$171 ﹤0.01% 6904
2024
Q3 		$0 Sell
5
-3
-38% -$93 ﹤0.01% 6867
2024
Q2 		$0 Buy
8
+4
+100% +$220 ﹤0.01% 7067
2024
Q1 		$0 Hold
4
– – ﹤0.01% 7027
2023
Q4 		$0 Hold
4
– – ﹤0.01% 7126
2023
Q3 		$1K Sell
4
-3
-43% -$786 ﹤0.01% 6868
2023
Q2 		$2K Sell
7
-29
-81% -$13.1K ﹤0.01% 6849
2023
Q1 		$24K Sell
36
-42
-54% -$37.3K ﹤0.01% 5957
2022
Q4 		$67K Buy
78
+68
+680% +$85.6K ﹤0.01% 5721
2022
Q3 		$11K Buy
10
+4
+67% +$5.29K ﹤0.01% 6375
2022
Q2 		$5K Sell
6
-38
-86% -$39.1K ﹤0.01% 6632
2022
Q1 		$67K Sell
44
-179
-80% -$242K ﹤0.01% 5897
2021
Q4 		$399K Buy
223
+53
+31% +$142K ﹤0.01% 4678
2021
Q3 		$563K Buy
170
+16
+10% +$56K ﹤0.01% 4243
2021
Q2 		$676K Buy
154
+91
+144% +$359K ﹤0.01% 4000
2021
Q1 		$308K Buy
63
+49
+350% +$276K ﹤0.01% 4590
2020
Q4 		$26K Buy
14
+1
+8% +$374 ﹤0.01% 5936
2020
Q3 		$5K Buy
13
+12
+1,200% +$4.65K ﹤0.01% 6127
2020
Q2 		$0 Hold
1
– – ﹤0.01% 6628
2020
Q1 		$0 Buy
+1
New +$565 ﹤0.01% 6677
2019
Q4 		– Hold
0
– – – 6825
2019
Q3 		– Hold
0
– – – 6704

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Royal Bank of Canada's BNGO Position: Q1 2026 in Review

Royal Bank of Canada reduced its Bionano Genomics (BNGO) stake by 8.3% in Q1 2026, selling an estimated $1 and leaving 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7133.

Royal Bank of Canada first reported a position in BNGO in Q1 2020 and has held it in 25 quarters since. The position peaked at $676K in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Royal Bank of Canada held 11 shares of Bionano Genomics worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 1 Bionano Genomics share in Q1 2026, an estimated $1.
  • Bionano Genomics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7133 holding.
  • Royal Bank of Canada first reported a position in Bionano Genomics in Q1 2020 and has held it in 25 quarters since.
  • Royal Bank of Canada's Bionano Genomics position peaked at $676K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.